The Alabama Department of Public Health (ADPH) is investigating reports of side effects from injections of the antibiotic ceftriaxone, also known as Rocefin.
MONTGOMERY, Ala. (WTVA) — The Alabama Department of Public Health (ADPH) is investigating reports of side effects from injections of the antibiotic ceftriaxone, also known as Rocefin.
ADPH had received 11 reports as of Tuesday, January 21st.
These shots were administered within the past few months in Alabama, but ADPH did not identify the individuals or clinics that received the doses.
“Some of the cases investigated showed signs and symptoms consistent with an anaphylactic reaction, including urticaria, pruritus, hypotension, and hypoxia, and were successfully treated with anti-anaphylactic measures.” ADPH made the announcement on Tuesday.
ADPH also said, “The study subjects had a variety of comorbidities, and a specific causal relationship between ceftriaxone and these reactions has not been determined at this time,” ADPH said in a statement Tuesday.
“While this research is ongoing, it is important to note that, as with other injectable antibiotics, allergic reactions may occur and steps should be taken to monitor and respond appropriately to such reactions. It is important to note that cephalosporins, such as ceftriaxone, can cause allergic reactions in 0.5% to 2.5% of patients,” ADPH said.
It is unclear whether this will affect Rocefin doses in Mississippi. The Mississippi State Department of Health provided the following statement to WTVA:
“We are aware of the situation and are closely monitoring it.”
However, some clinics in northern Mississippi (including RedMed clinics) pontotoku and new albany — Announced that out of an abundance of caution, we are suspending the use of Rocephin until further notice.
